Use of Colonoscopy and Flexible Sigmoidoscopy Among African Americans and Whites in a Low-Income Population by Peterson, Neeraja B et al.
VOLUME 5: NO. 1 JANUARY 2008
Use of Colonoscopy and Flexible 
Sigmoidoscopy Among African Americans 
and Whites in a Low-Income Population
LETTER
Suggested citation for this article: Peterson NB, Murff HJ, 
Fowke JH, Cui Y, Hargreaves M, Signorello LB, et al. Use 
of colonoscopy and flexible sigmoidoscopy among African 
Americans  and  whites  in  a  low-income  population  [let-
ter]. Prev Chronic Dis 2008;5(1). http://www.cdc.gov/pcd/
issues/2008/jan/07_0160.htm. Accessed [date].
PEER REVIEWED
To the Editor:
Colorectal cancer is the third most common incident can-
cer and the second most common cause of cancer-related 
death in the United States. The disease is largely prevent-
able with screening. In the United States, colorectal cancer 
mortality is higher among African Americans than among 
whites, possibly because of inequalities in the delivery of 
screening, diagnostic, and therapeutic regimens (1,2). To 
elucidate the role of race in the use of two recommended 
screening tests for colorectal cancer (i.e., colonoscopy and 
flexible  sigmoidoscopy),  we  compared  data  on  test  use 
among African Americans and white participants in the 
Southern Community Cohort Study (SCCS).
The SCCS is a large-scale prospective cohort study of 
cancer (3). We analyzed baseline data collected from par-
ticipants  at  enrollment  during  2002  through  2006  from 
48 community health centers in a 12-state region in the 
southeastern United States. Sixty-three percent of the par-
ticipants reported annual household incomes of less than 
$15,000, and an additional 21% reported annual household 
incomes of less than $25,000. Questions included “Have 
you ever had a sigmoidoscopy?” and “Have you ever had a 
colonoscopy?” If respondents had not had either of the two 
tests within the recommended time frame or had never had 
either test, they were asked to indicate a reason using a list 
we provided. We did not elicit information about screening 
using fecal occult blood test or barium enema.
Men and women aged 50 years or older at enrollment 
were eligible for analysis (n = 25,786). We excluded people 
who were not African American or white (n = 1370) and 
people who reported a prior diagnosis of colon or rectal 
cancer (n = 134), resulting in 24,282 subjects for analysis. 
We defined outcome variables as 1) having ever had test-
ing with a sigmoidoscopy or colonoscopy or 2) having had 
recommended testing, which is defined by current guide-
lines (4) as a sigmoidoscopy in the previous 5 years or a 
colonoscopy in the previous 10 years.
We  used  chi-square  tests  with  P  values  to  compare 
participants’ demographic characteristics (age, race, and 
sex) and socioeconomic (SES) indexes (annual household 
income,  education,  and  marital  and  health  insurance 
status)  across  categories  of  test-use  status.  We  used 
multivariable logistic regression to calculate odds ratios 
(ORs)  and  95%  confidence  intervals  (CIs)  summarizing 
the  association  between  test-use  prevalence  and  race, 
stratified by sex, after adjustment for demographic and 
SES variables. We used generalized estimating equations 
to fit the model to account for the possibility that data 
were correlated from participants recruited within each 
community health center.
African American respondents were younger, were less 
likely to have completed high school, and reported slightly 
lower household incomes than white respondents. Among 
all respondents, 38.2% reported having a sigmoidoscopy or 
colonoscopy, and 34.8% reported having the recommended 
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testing. Having any type of testing was positively associ-
ated with increasing age, higher household income, higher 
education, having been married, having private or public 
health insurance, and having had a medical visit within 
the previous year.
Among African Americans, only 30.6% of men and 38.2% 
of women reported ever having had a sigmoidoscopy or 
colonoscopy, compared with 38.8% of white men (adjusted 
OR, 0.93; 95% CI, 0.83–1.03) and 47.4% of white women 
(adjusted OR, 0.80; 95% CI, 0.72–0.88) (Table 1). When we 
examined prevalence by type of test, however, we found 
that the reduced use of endoscopy was entirely accounted 
for by the reduced use of colonoscopy. African American 
men and women were similarly likely to have ever had a 
sigmoidoscopy. The deficit among African Americans in the 
number who had ever had a colonoscopy was seen in both 
sexes, but was particularly marked among women (men, 
adjusted OR, 0.89; 95% CI, 0.80–0.98; women, adjusted 
OR, 0.70; 95% CI, 0.65–0.76). For both sigmoidoscopy and 
colonoscopy  among  African  American  men  and  women, 
the ORs associated with recommended testing were higher 
(i.e., less of a deficit) than the ORs associated with ever 
having had the tests. African Americans were significantly 
more likely than whites to have had a sigmoidoscopy at 
recommended intervals.
When participants who had not had either recommend-
ed test were asked to indicate why, most reported their 
doctor had not recommended the test (Table 2). The next 
most common reason was cost.
The limitations of our study included not distinguishing 
between colonoscopies and sigmoidoscopies performed for 
screening  versus  diagnostic  purposes,  not  asking  about 
fecal occult blood tests or barium enemas, and relying on 
self-reported data.
In summary, we found lower use of colonoscopy among 
African Americans than among whites. Although future 
studies are needed to confirm these findings, we suggest 
that the lower use of colonoscopy may contribute to the 
higher rates of colorectal cancer mortality among African 
Americans.
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Tables
Table 1. Prevalence of Endoscopic Testing for Colorectal Cancer Among African American and White Men and Women, 
Southern Community Cohort Study, 2002—2006
Test
African American 
Men 
(n = 6945)a 
No. (%)
White Men 
(n = 1938)a 
No.  (%)
OR, Unadjustedb 
(95% CI)
OR, Adjustedb,c 
(95% CI)
Sigmoidoscopy
Ever had test 1148 (16.8) 1 (17.) 0.96 (0.79-1.16) 1.12 (0.95-1.)
Recommended testingd 970 (14.2) 27 (12.4) 1.18 (0.95-1.48) 1.9 (1.14-1.70)
Colonoscopy
Ever had test 14 (21.0) 581 (0.4) 0.77 (0.68-0.86) 0.89 (0.80-0.98)
Recommended testingd 152 (19.9) 56 (28.1) 0.81 (0.72-0.91) 0.94 (0.84-1.06)
Either test
Ever had test(s) 2092 (0.6) 742 (8.8) 0.79 (0.70-0.89) 0.9 (0.8-1.0)
Recommended testingd 1907 (28.1) 650 (4.2) 0.88 (0.77-1.01) 1.04 (0.91-1.19)
Test
African American 
Women 
(n = 11,163)a 
No. (%)
White Women 
(n = 4236)a 
No.  (%)
OR, Unadjustedb 
(95% CI)
OR, Adjustedb,c 
(95% CI)
Sigmoidoscopy
Ever had test 1979 (18.0) 790 (18.8) 0.98 (0.85-1.14) 1.00 (0.86-1.16)
Recommended testingd 157 (14.4) 517 (12.4) 1.24 (1.07-1.44) 1.24 (1.07-1.45)
Colonoscopy
Ever had test 106 (28.) 1701 (40.5) 0.68 (0.62-0.75) 0.70 (0.65-0.76)
Recommended testingd 294 (26.9) 1556 (7.2) 0.7 (0.67-0.80) 0.75 (0.70-0.81)
Either test
Ever had test(s) 4201 (8.2) 1990 (47.4) 0.78 (0.71-0.87) 0.80 (0.72-0.88)
Recommended testingd 787 (4.8) 1726 (41.) 0.87 (0.79-0.96) 0.89 (0.82-0.98)
 
OR indicates odds ratio; CI, confidence interval. 
a Approximately 2% of outcome data in each test category was missing from analysis. 
b Referent group is white study participants of same sex.  
c Adjusted for age, education, income, and marital and insurance status. 
d Recommended testing refers to having a sigmoidoscopy within the last 5 years or having a colonoscopy within the last 10 years.VOLUME 5: NO. 1
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Table 2. Reasons Given by African American and White Participants for Not Having Recommended Endoscopic Testing for 
Colorectal Cancer, Southern Community Cohort Study, 2002—2006a
Reason
African American 
(n = 11,994) 
No.  (%)
White 
(n = 3706) 
No.  (%) P valueb
Doctor did not recommend test 7698 (64.2) 2245 (60.6) <.001
Forgot to do it 215 (1.8) 59 (1.6) .41
Have fear of finding cancer 14 (2.6) 90 (2.4) .52
Put it off or too busy 450 (.8) 202 (5.5) <.001
Embarrassment 109 (0.9) 77 (2.1) <.001
Cost 881 (7.4) 525 (14.2) <.001
May experience pain or discomfort during the test 41 (.5) 209 (5.6) <.001
None of the above 2528 (21.1) 682 (18.4) <.001
 
a Among participants who reported not having a sigmoidoscopy within the last 5 years or a colonoscopy within the last 10 years. Participants were permitted 
to select more than one reason. 
b P values were determined by chi-square tests.
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